Tecemotide (L-BLP25) in Prostate Cancer

Clinical trial NCT01496131 · COMPLETED

Trial details

NCT number: NCT01496131
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2011-10-24
Primary completion: 2016-11-25
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.